• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

喉癌术后复发相关因素的临床分析

[Clinical analysis of relevant factors causing laryngeal cancer postoperative recurrence].

作者信息

Guo Rui, Huang De-liang, Li Hui, Yang Wei-yan, Han Dong-yi

机构信息

Department of Otorhinolaryngology, PLA General Hospital, Beijing 100853, China.

出版信息

Zhonghua Er Bi Yan Hou Ke Za Zhi. 2003 Aug;38(4):300-3.

PMID:14743644
Abstract

OBJECTIVE

To investigate the clinical relevant factors causing laryngeal cancer postoperative recurrence and analysis the reasons of treatment failure.

METHODS

Totally, 574 cases of laryngeal cancer from 1958 to 1999 treated in ENT department of PLA general hospital were retrospectively reviewed. All the patients were observed for 3 years postoperatively, and finally 56 cases of the recurrence were diagnosed. We analyzed the factors possibly causing the recurrence including age, sex, history, time in hospital, smoke, grade of pathology, combination, tumor stage, transfusion, radiotherapy, operation manners and cervical lymph metastasis node grade.

RESULTS

By statistic analysis, tumor grade (P = 0.0002), operation (P = 0.0017), transfusion (P = 0.0001), radiotherapy (P = 0.0001) and cervical lymphatic metastasis node grade(P = 0.0228) have significant meaning with laryngeal cancer postoperative recurrence.

CONCLUSION

Tumor grade, transfusion, radiotherapy, operation and cervical lymph metastasis node grade are main factors which may cause neoplasm postoperative recurring.

摘要

目的

探讨喉癌术后复发的临床相关因素并分析治疗失败的原因。

方法

回顾性分析1958年至1999年解放军总医院耳鼻咽喉科收治的574例喉癌患者。所有患者术后观察3年,最终确诊复发56例。分析可能导致复发的因素,包括年龄、性别、病史、住院时间、吸烟、病理分级、联合治疗、肿瘤分期、输血、放疗、手术方式及颈部淋巴结转移分级。

结果

经统计学分析,肿瘤分级(P = 0.0002)、手术(P = 0.0017)、输血(P = 0.0001)、放疗(P = 0.0001)及颈部淋巴结转移分级(P = 0.0228)与喉癌术后复发有显著意义。

结论

肿瘤分级、输血、放疗、手术及颈部淋巴结转移分级是可能导致肿瘤术后复发的主要因素。

相似文献

1
[Clinical analysis of relevant factors causing laryngeal cancer postoperative recurrence].喉癌术后复发相关因素的临床分析
Zhonghua Er Bi Yan Hou Ke Za Zhi. 2003 Aug;38(4):300-3.
2
[Postoperative recurrence-related factors of 125 patients with cT1-2N0 squamous cell carcinoma of the oral tongue].[125例cT1-2N0期舌鳞状细胞癌患者术后复发相关因素分析]
Ai Zheng. 2007 Jun;26(6):661-5.
3
[Correlation of cervical lymphatic metastasis to prognosis of T3-T4 glottic cancer].[喉癌T3-T4期颈部淋巴结转移与预后的相关性]
Ai Zheng. 2006 Oct;25(10):1271-4.
4
[Clinical analysis of relevant factors causing postoperative recurrence of laryngeal cancer after partial laryngectomy].[喉部分切除术后喉癌复发相关因素的临床分析]
Zhonghua Zhong Liu Za Zhi. 2013 May;35(5):377-81. doi: 10.3760/cma.j.issn.0253-3766.2013.05.012.
5
[Neck relapse-related factors of cN0 stage supraglottic cancer].[cN0 期声门上型癌颈部复发相关因素]
Ai Zheng. 2006 Mar;25(3):355-8.
6
Predictors of local failure in early laryngeal cancer.早期喉癌局部失败的预测因素。
Neoplasma. 2005;52(6):483-8.
7
[Correlation of cervical lymphatic metastasis to prognosis of glottic carcinoma: a report of 333 cases].[声门癌颈淋巴结转移与预后的相关性:附333例报告]
Ai Zheng. 2007 Oct;26(10):1138-42.
8
[Treatment and prognosis of stage T3 glottic laryngeal cancer--a report of 65 cases].T3期声门型喉癌的治疗与预后——附65例报告
Ai Zheng. 2006 Jan;25(1):85-7.
9
[Recurrence patterns of esophageal cancer after Ivor-Lewis esophagectomy--a report of 196 cases].[Ivor-Lewis食管切除术后食管癌的复发模式——196例报告]
Ai Zheng. 2006 Jan;25(1):96-9.
10
Neck management in patients undergoing postradiotherapy salvage laryngeal surgery for recurrent/persistent laryngeal cancer.接受复发性/持续性喉癌放疗后挽救性喉手术患者的颈部处理
Laryngoscope. 2006 Oct;116(10):1864-6. doi: 10.1097/01.mlg.0000234917.08822.cd.

引用本文的文献

1
Attenuation of EGFL7 inhibits human laryngocarcinoma cells growth and invasion.EGFL7 的衰减抑制人喉癌细胞的生长和侵袭。
Int J Clin Exp Med. 2015 Mar 15;8(3):3141-55. eCollection 2015.